Ledger.Open graph →
SEC Form D · Amendment · filed January 26, 2024

Jnana Therapeutics Inc

Offering
$107.0M
Sold
$107.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Annie C. Chen · Boston, MADirectorCarlo W. Rizzuto · Boston, MADirectorTerrance G. Mcguire · Waltham, MADirectorJoanne D. Kotz · Boston, MAExec · DirectorDonald W. Nicholson · Boston, MADirectorCaroline S. Beer · Boston, MAExecMatthew W. Hammond · Boston, MADirectorBrian M. Cali · Boston, MADirectorDouglas W. Pagan · Boston, MAExecRonald C. Renaud, Jr · Cambridge, MADirectorGeorge W. Vratsanos · Boston, MAExecAnnie C. Chen · Boston, MADirectorDouglas W. Pagan · Boston, MAExecRonald C. Renaud, Jr · Cambridge, MADirectorGeorge W. Vratsanos · Boston, MAExecCarlo W. Rizzuto · Boston, MADirectorTerrance G. Mcguire · Waltham, MADirectorJoanne D. Kotz · Boston, MAExec · DirectorDonald W. Nicholson · Boston, MADirectorCaroline S. Beer · Boston, MAExecMatthew W. Hammond · Boston, MADirectorBrian M. Cali · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗